Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.

Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA recruitment status notice indicates the study is no longer enrolling participants. New guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, and the 'Intervention/Treatment' heading formatting was updated alongside a revision note to v3.6.0.SummaryDifference0.5%

- Check23 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This is a metadata update and does not modify study details or user-facing information.SummaryDifference0.1%

- Check44 days agoChange DetectedA new page revision (v3.5.4) was added to replace the previous revision (v3.5.3). This indicates an updated version of the study details page.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s displayed revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a site release/version change without altering the underlying study details.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check103 days agoChange DetectedRevision: v3.5.0 has been added, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.